Primary prevention

Citations 281-290 of 558 total displayed.

Past content (since Feb 1999):

Hypertension
Additive Beneficial Effects of Losartan Combined With Simvastatin in the Treatment of Hypercholesterolemic, Hypertensive Patients: Kwang Kon Koh, Michael J. Quon, Seung Hwan Han, Wook-Jin Chung, Jeong Yeal Ahn, Yiel-Hea Seo, Moon Ho Kang, Tae Hoon Ahn, In Suck Choi, and Eak Kyun Shin
Circulation 2004;110:3687-3692; published online before print as doi:10.1161/01.CIR.0000143085.86697.13 [Abstract] [Full text]

Vascular Medicine
Novel Antiinflammatory Vascular Benefits of Systemic and Stent-Based Delivery of Ethylisopropylamiloride: Yong-Xiang Chen, Xiaoli Ma, Stewart Whitman, and Edward R. O’Brien
Circulation 2004;110:3721-3726; published online before print as doi:10.1161/01.CIR.0000146790.51331.BA [Abstract] [Full text]

Articles
Additive Beneficial Effects of Losartan Combined With Simvastatin in the Treatment of Hypercholesterolemic, Hypertensive Patients: Kwang Kon Koh, Michael J. Quon, Seung Hwan Han, Wook-Jin Chung, Jeong Yeal Ahn, Yiel-Hea Seo, Moon Ho Kang, Tae Hoon Ahn, In Suck Choi, and Eak Kyun Shin
Circulation published November 29, 2004, doi:10.1161/01.CIR.0000143085.86697.13 [Abstract]

AHA Conference Proceedings
Prevention Conference VII: Obesity, a Worldwide Epidemic Related to Heart Disease and Stroke: Group II: Age-Dependent Risk Factors for Obesity and Comorbidities: Sachiko T. St. Jeor, Laura L. Hayman, Stephen R. Daniels, Matthew W. Gillman, George Howard, Catherine M. Law, Cora Elizabeth Lewis, and Eric Poehlman
Circulation 2004;110:e471-475e, doi:10.1161/01.CIR.0000140092.48032.D2 [Full text]

Arrhythmia/Electrophysiology
Sagittal Abdominal Diameter and Risk of Sudden Death in Asymptomatic Middle-Aged Men: The Paris Prospective Study I: J.P. Empana, P. Ducimetiere, M.A. Charles, and X. Jouven
Circulation 2004;110:2781-2785; published online before print as doi:10.1161/01.CIR.0000146395.64065.BA [Abstract] [Full text]

Coronary Heart Disease
Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria: Folkert W. Asselbergs, Gilles F.H. Diercks, Hans L. Hillege, Ad J. van Boven, Wilbert M.T. Janssen, Adriaan A. Voors, Dick de Zeeuw, Paul E. de Jong, Dirk J. van Veldhuisen, Wiek H. van Gilst for the Prevention of Renal and Vascular Endstage Disease Intervention Trial Investigators
Circulation 2004;110:2809-2816; published online before print as doi:10.1161/01.CIR.0000146378.65439.7A [Abstract] [Full text]

Vascular Medicine
Anti–Glycoprotein VI Treatment Severely Compromises Hemostasis in Mice With Reduced ${alpha}$ ₂ß₁ Levels or Concomitant Aspirin Therapy: Sabine Grüner, Miroslava Prostredna, Barsom Aktas, Alexandra Moers, Valerie Schulte, Thomas Krieg, Stefan Offermanns, Beate Eckes, and Bernhard Nieswandt
Circulation 2004;110:2946-2951; published online before print as doi:10.1161/01.CIR.0000146341.63677.3C [Abstract] [Full text]

Articles
Novel Antiinflammatory Vascular Benefits of Systemic and Stent-Based Delivery of Ethylisopropylamiloride: Yong-Xiang Chen, Xiaoli Ma, Stewart Whitman, and Edward R. O’Brien
Circulation published November 1, 2004, doi:10.1161/01.CIR.0000146790.51331.BA [Abstract]

Preventive Cardiology Comparison of the Associations of Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in Patients With the Metabolic Syndrome in the Insulin Resistance Atherosclerosis Study: Naveed Sattar, Ken Williams, Allan D. Sniderman, Ralph D’Agostino, Jr, and Steven M. Haffner
Circulation 2004;110:2687-2693; published online before print as doi:10.1161/01.CIR.0000145660.60487.94 [Abstract] [Full text]

Articles
Novel Antiinflammatory Vascular Benefits of Systemic and Stent-Based Delivery of Ethylisopropylamiloride: Yong-Xiang Chen, Xiaoli Ma, Stewart Whitman, and Edward R. O’Brien
Circulation published October 25, 2004, doi:10.1161/01.CIR.0000146790.51331.BA [Abstract]

Subspecialty Collections Home

Show Primary prevention
collections from other journals.